Cost-effectiveness of empagliflozin in the treatment of Malaysian patients with chronic heart failure and preserved or mildly reduced ejection fraction.

PLoS One · 2024 · PMC11343421 · PMID 39178204

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an observed trendno p-value reported

Taking into account clinical plausibility as well as an observed trend towards lower CV death with EPG treatment, EPG was assumed to have a treatment effect on CV death and no effect on all-cause death.

also in 229 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.